rs653178 — SH2B3 ATXN2/SH2B3 12q24 pleiotropic locus

Pleiotropic 12q24 locus variant in SH2B3 (LNK) modulating JAK-STAT cytokine signaling, with associations spanning blood pressure, celiac disease, and coronary artery disease

See your personal result for SH2B3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The JAK-STAT Gatekeeper at the Most Pleiotropic Locus in the Genome

The 12q24 chromosomal region is often called the most pleiotropic locus in the human genome — a single genomic neighbourhood whose variants have been credibly associated with systolic blood pressure, celiac disease, coronary artery disease, rheumatoid arthritis, type 1 diabetes, chronic kidney disease, and hematological traits. At the centre of this landscape sits SH2B3 (also called LNK), an adaptor protein that acts as a master brake on cytokine and growth-factor signaling.

The Mechanism

SH2B3 encodes the LNK protein, which contains an SH2 domain that binds phosphorylated tyrosine residues on JAK kinases and cytokine receptors, physically blocking downstream signal propagation. LNK is a negative regulator of JAK-STAT signalling11 JAK-STAT signalling
The JAK-STAT cascade transmits signals from cell-surface cytokine receptors to gene transcription in the nucleus across multiple tissues: bone marrow progenitors, immune cells, and adipose tissue.

When LNK expression is reduced, the braking effect on JAK-STAT is weakened. In adipose tissue, this allows IL-15-dependent innate lymphoid cells22 innate lymphoid cells
Group 1 ILCs — natural killer-like immune cells that reside in fat tissue and promote insulin resistance when overactivated to expand and accumulate, promoting local inflammation and impairing insulin signaling. In vascular tissue, reduced LNK function allows platelets to release elevated levels of oxidized phospholipids that trigger NETosis33 NETosis
Neutrophil extracellular trap formation — a form of neutrophil cell death that releases DNA-protein complexes promoting thrombosis, contributing to arterial thrombosis risk.

The Evidence

The CHARGE Consortium GWAS44 CHARGE Consortium GWAS
Levy et al. Genome-wide association study of blood pressure and hypertension. Nature Genetics, 2009 (n=63,569) identified the SH2B3/12q24 locus as genome-wide significant for systolic blood pressure, placing it among the earliest and most robustly replicated blood pressure loci.

Functional work in mice showed that Lnk-deficient animals develop impaired glucose tolerance when fat-enriched diets are applied — an effect reversed by depleting group 1 innate lymphoid cells or by JAK inhibitor treatment. In adipocytes, LNK knockdown worsened palmitate-induced lipotoxicity55 palmitate-induced lipotoxicity
Saturated fatty acid-driven apoptosis of fat cells, a hallmark of obesity-related insulin resistance by reducing Akt phosphorylation and amplifying mitochondrial dysfunction.

A cross-trait GWAS analysis found that rs653178 at SH2B3/ATXN266 rs653178 at SH2B3/ATXN2
Jansen et al. Molecular Genetics and Genomics, 2015 was the only celiac-associated SNP to show study-wide significant association with coronary artery disease, with consistent directional effects across both conditions — underscoring the locus's pleiotropic immune-metabolic mechanism rather than a simple disease-to-disease link.

Practical Actions

Routine blood pressure monitoring identifies early hypertensive trends at this locus before they become symptomatic.

Interactions

The nearby rs3184504 (SH2B3 W262R missense variant) is in linkage disequilibrium with rs653178 and has been associated with autoimmune and hematological phenotypes. The ATXN2 gene sits immediately adjacent to SH2B3 at this locus; ATXN2 regulates RNA processing and trophic receptor internalization, adding a second functional layer to the 12q24 pleiotropy that is largely independent of the SH2B3 immune-metabolic pathway.

Genotype Interpretations

What each possible genotype means for this variant.

TT Baseline JAK Brake Normal

Common protective genotype — normal JAK-STAT regulation

You have two copies of the T allele at rs653178, the most common genotype globally (~46% of people across all ancestries). Your LNK protein functions at typical levels, providing normal restraint on JAK-STAT cytokine signaling in adipose tissue, blood vessels, and immune cells.

This genotype is associated with population-average blood pressure and insulin sensitivity at this locus. The 12q24 region contributes to many complex traits, but the TT genotype does not add incremental risk from this specific variant.

CT Reduced JAK Brake Intermediate

One risk allele — moderately reduced LNK signaling brake

LNK/SH2B3 acts as a phosphotyrosine-binding brake on JAK2 and downstream cytokine receptors. In adipose tissue, normal LNK levels prevent IL-15-driven expansion of pro-inflammatory group 1 ILCs (innate lymphoid cells). When LNK expression falls, these cells accumulate and secrete cytokines that impair insulin receptor signaling. The same JAK-STAT dysregulation in vascular tissue permits heightened platelet activation and neutrophil reactivity.

For heterozygotes, the effect is intermediate — enough to warrant attention to blood pressure, but not the intensive monitoring appropriate for CC homozygotes.

CC Impaired JAK Brake High Risk

Two risk alleles — meaningfully reduced LNK function, elevated metabolic and vascular risk

LNK/SH2B3 is a master negative regulator of JAK-STAT signaling across immune and metabolic tissues. Reduced LNK function in platelets allows oxidized phospholipid release that triggers NETosis in neutrophils, increasing arterial thrombosis risk.

Clinically, the SH2B3/12q24 locus has genome-wide significant associations with systolic blood pressure, and rs653178 shows consistent directional effects across celiac disease and coronary artery disease.